This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Seung Wan Hahm: Innovator in Antibody Development
Introduction
Seung Wan Hahm is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on therapeutic applications that can improve patient outcomes.
Latest Patents
Hahm holds a patent for "Antibodies against growth differentiation factor 15 and uses thereof." This patent describes monoclonal antibodies that bind to the human Growth Differentiation Factor 15 protein, also known as GDF15. The patent outlines pharmaceutical compositions and methods of treatment that utilize these antibodies, showcasing their potential in medical applications.
Career Highlights
Seung Wan Hahm is currently associated with Novartis AG, a leading global healthcare company. His role involves research and development in the field of antibody therapeutics, where he applies his expertise to advance innovative treatments.
Collaborations
Hahm has collaborated with esteemed colleagues, including Hong M Chen and Rajiv Chopra. These partnerships enhance the research efforts and contribute to the development of groundbreaking therapies.
Conclusion
Seung Wan Hahm's work in antibody development exemplifies the impact of innovation in biotechnology. His contributions are paving the way for new therapeutic options that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile